版本:
中国

BRIEF-Abbott says findings from Lotus I study may have important implications for women undergoing IVF

March 8 Abbott Laboratories

* Abbott Laboratories - findings from Lotus I study have potential to have important implications for women undergoing IVF

* Abbott Laboratories - Lotus I , a Phase 3 study, evaluated effects of oral dydrogesterone in luteal support in IVF

* Abbott Laboratories - findings of study provide clinical evidence for an oral treatment option

* Abbott Laboratories - in Lotus I study, oral dydrogesterone had similar efficacy and tolerability to micronized vaginal progesterone

* Abbott Laboratories - in Lotus I study, oral dydrogesterone achieved similar results to mvp in terms of presence of fetal heart beats at 12 weeks gestation Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐